Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883175 · ClinicalTrials.gov registry record · NA

Evolution of the Chicago Classification: Bridging Physiology and Mechanics

A NA study of Dysphagia and Achalasia, Esophageal, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
575
Enrollment target
1
Study location

NCT06883175: Recruiting NA study of Dysphagia and Achalasia, Esophageal, sponsored by Northwestern University.

NCT06883175 is a NA study of Dysphagia and Achalasia, Esophageal that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 575 participants, above the 156-participant average among 35 other Dysphagia trials with a reported enrollment target (269% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883175, a NA study of Dysphagia and Achalasia, Esophageal, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
575 participants
Enrollment target
1
Study location

Study Summary

Swallowing difficulties are extremely common and result in substantial morbidity, reduction in the quality of life, and mortality related to malnutrition and complications from regurgitation and aspiration. Unfortunately, our understanding regarding the pathophysiology of dysphagia and GERD has been hampered by focusing predominantly on circular muscle activity and ignoring the essential biomechanical properties of the esophageal wall that promote normal emptying. Our initial work explored the relationship between intrabolus pressure (IBP) and esophagogastric junction (EGJ) compliance as a metric for outflow resistance. This work highlighted the direct relationship between IBP and EGJ opening and was the foundation for the development of the classification scheme utilized around the world to diagnose esophageal motor disorders: "the Chicago Classification" (CC). Despite this improved understanding focused on bolus transit dynamics, there are still significant gaps in our scientific understanding centered on the lack of a true correlate for symptoms, reliable predictive models and effective treatments for Functional dysphagia, IEM and EGJOO. Given these limitations, we have developed novel approaches that combine assessments of primary and secondary peristalsis (a NeuroMyogenic Model of esophageal function). These will leverage our recent findings supporting the importance of the esophageal response to distension in bolus clearance, noting that this response of the esophageal wall to bolus retention or reflux is one of the most essential functions of the esophagus in preventing complications of aspiration, or reflux injury. We will also include an assessment of esophageal geometry and wall biomechanics (elasticity/dilatation) as these carry essential interactions with esophageal function that are overlooked in the current diagnostic paradigms. In order to test our hypothesis that wall mechanics are a major determinant of esophageal diseases, we had to develop new ap

Primary Outcome

A 10 item dysphagia/food impaction questionnaire measured on a 6-point Likert scale from "none" to "severe" with higher scores indicating a greater degree of dysphagia

Interventions

  • DIAGNOSTIC_TEST FLIP
  • DIAGNOSTIC_TEST HRM
  • OTHER Prucalopride

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 575 participants
Start Date 2024-09-01
Est. Completion 2029-06-30
Phase NA
Northwestern University

1,209 total trials

What NCT06883175 shows while recruiting

NCT06883175 is an interventional study that assigns participants to a tested intervention. The registered 575 participants enrollment target is mid-sized for trials with a published cap, above the 156-participant average among 35 other Dysphagia trials with a reported enrollment target (269% higher).

The record links to 3 conditions, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which FLIP is the first listed.

NCT06883175 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06883175 about?

NCT06883175 is a clinical study titled "Evolution of the Chicago Classification: Bridging Physiology and Mechanics". Swallowing difficulties are extremely common and result in substantial morbidity, reduction in the quality of life, and mortality related to malnutrition and complications from regurgitation and aspiration. Unfortunately, our understanding regarding the pathophysiology of dysphagia and GERD has been...

What is the current status of trial NCT06883175?

This trial is currently recruiting. It is a NA study. The enrollment target is 575 participants. The study started on 2024-09-01. Estimated completion is 2029-06-30.

What conditions does trial NCT06883175 study?

This clinical trial studies the following conditions: Dysphagia, Achalasia, Esophageal, Ineffective Esophageal Motility.

What interventions are being tested in trial NCT06883175?

The interventions under investigation include: FLIP (DIAGNOSTIC_TEST), HRM (DIAGNOSTIC_TEST), Prucalopride (OTHER).

Who is sponsoring clinical trial NCT06883175?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06883175 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06883175's enrollment target sits among peer trials

575 4th of 35 higher than 32 of 35 other Dysphagia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02610439 · 575 participants

    Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

  • NCT05919264 · 575 participants · Phase 1

    FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • NCT06583148 · 575 participants · NA

    A Smoke-Free Home Intervention in Tribal Communities

  • NCT04931810 · 576 participants · NA

    Urban and Reservation Implementation of All Nations Breath of Life

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06883175, the US trial registry maintained by the National Library of Medicine. NCT06883175 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.